Regulatory Role of Peritoneal B Cells in EAE

1. Crampton SP, Voynova E, Bolland S. Innate pathways to B-cell activation and tolerance. Ann N Y Acad Sci. 2010; 1183: 58-68.10.1111/j.1749-6632.2009.05123.x342202120146708Search in Google Scholar

2. Meyer-Bahlburg A, Rawlings DJ. B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev. 2008; 7(4): 313-316.10.1016/j.autrev.2007.11.027276348318295736Search in Google Scholar

3. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol. 1993; 11: 501-538.10.1146/annurev.iy.11.040193.0024418476571Search in Google Scholar

4. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011; 11(1): 34-46.10.1038/nri290121151033Search in Google Scholar

5. Montecino-Rodriguez E, Dorshkind K. B-1 B cell development in the fetus and adult. Immunity. 2012; 36(1): 13-21.10.1016/j.immuni.2011.11.017326903522284417Search in Google Scholar

6. O’Garra A, Stapleton G, Dhar V, et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol. 1990; 2(9): 821-832.10.1093/intimm/2.9.8211703785Search in Google Scholar

7. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005 ;23: 683-747.10.1146/annurev.immunol.23.021704.11570715771584Search in Google Scholar

8. Ben-Nun A, Cohen IR. Vaccination against autoimmune encephalomyelitis (EAE): attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line. Eur J Immunol. 1981; 11(11): 949-952.10.1002/eji.18301111197327196Search in Google Scholar

9. Costantino CM, Baecher-Allan C, Hafler DA. Multiple sclerosis and regulatory T cells. J Clin Immunol. 2008; 28(6): 697-706.10.1007/s10875-008-9236-x275228718763026Search in Google Scholar

10. O’Connor RA, Anderton SM. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol. 2008; 193(1-2): 1-11.10.1016/j.jneuroim.2007.11.01618077005Search in Google Scholar

11. Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol. 2004; 16(2): 249-256.10.1093/intimm/dxh02914734610Search in Google Scholar

12. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood.2008; 112(5): 1570-1580.10.1182/blood-2008-02-078071251887318725575Search in Google Scholar

13. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF. B-lymphocyte contributions to human autoimmune disease. Immunol Rev. 2008; 223: 284-299.10.1111/j.1600-065X.2008.00646.x18613843Search in Google Scholar

14. Bouaziz JD, Yanaba K, Venturi GM, et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A. 2007; 104(52): 20878-20883.10.1073/pnas.0709205105240923518093919Search in Google Scholar

15. Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin Immunol. 2008; 20(3): 332-338.10.1016/j.coi.2008.03.003247469418417336Search in Google Scholar

16. Hauser SL, Waubant E, Arnold DL, et al., HERMES Trial Group. B-cell depletion with rituximab in relapsing- remitting multiple sclerosis. N Engl J Med. 2008; 358(7): 676-688.10.1056/NEJMoa070638318272891Search in Google Scholar

17. Bar-Or A, Calabresi PA, Arnold D, et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, openlabel, phase I trial. Ann Neurol. 2008; 63(3): 395-400.10.1002/ana.2136318383069Search in Google Scholar

18. Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol. 2007; 178(10): 6092-6099.10.4049/jimmunol.178.10.609217475834Search in Google Scholar

19. Torring C, Petersen CC, Bjerg L, Kofod-Olsen E, Petersen T, Hollsberg P. The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis. J Neuroimmunol. 2013; 262(1-2): 92-99.10.1016/j.jneuroim.2013.06.00223856341Search in Google Scholar

20. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008; 118(10): 3420-3430.10.1172/JCI36030254285118802481Search in Google Scholar

21. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 1996; 184(6): 2271-2278.10.1084/jem.184.6.2271Search in Google Scholar

22. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002; 3(10): 944-950.10.1038/ni833Search in Google Scholar

23. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002; 16(2): 219-230.10.1016/S1074-7613(02)00274-1Search in Google Scholar

24. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003; 197(4): 489-501.10.1084/jem.20021293219386412591906Search in Google Scholar

25. Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008; 8(5): 391-397.10.1038/nri231518437156Search in Google Scholar

26. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012; 30: 221-241.10.1146/annurev-immunol-020711-07493422224776Search in Google Scholar

27. Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007; 178(12): 7868-7878.10.4049/jimmunol.178.12.786817548625Search in Google Scholar

28. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci. 2010; 1183: 38-57.10.1111/j.1749-6632.2009.05137.x20146707Search in Google Scholar

29. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008; 28(5): 639-650.10.1016/j.immuni.2008.03.01718482568Search in Google Scholar

30. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012; 491(7423): 264-268.10.1038/nature11501349369223064231Search in Google Scholar

31. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol. 2009; 182(12): 7459-7472.10.4049/jimmunol.0900270373312819494269Search in Google Scholar

32. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol. 1998; 161(7): 3299-3306. 10.4049/jimmunol.161.7.3299Search in Google Scholar

33. Lampropoulou V, Hoehlig K, Roch T, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol. 2008; 180(7): 4763-4773.10.4049/jimmunol.180.7.476318354200Search in Google Scholar

34. Horikawa M, Minard-Colin V, Matsushita T, Tedder TF. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J Clin Invest. 2011; 121(11): 4268-4280.10.1172/JCI59266320484722019587Search in Google Scholar

35. Miles K, Heaney J, Sibinska Z, et al. A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A. 2012; 109(3): 887-892.10.1073/pnas.1109173109327193122207622Search in Google Scholar

36. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003; 197(4): 489-501.10.1084/jem.20021293219386412591906Search in Google Scholar

37. Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol. 2009; 182(6): 3492-3502.10.4049/jimmunol.0803052408265919265127Search in Google Scholar

38. Poe JC, Smith SH, Haas KM, et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One. 2011; 6(7): e22464.10.1371/journal.pone.0022464314314821799861Search in Google Scholar

39. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012; 491(7423): 264-268.10.1038/nature11501349369223064231Search in Google Scholar

40. Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med. 2000; 192(4): 475-482.10.1084/jem.192.4.475219324110952717Search in Google Scholar

41. Matsushita T, Horikawa M, Iwata Y, Tedder TF. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol. 2010; 185(4): 2240-2252.10.4049/jimmunol.1001307371796820624940Search in Google Scholar

42. Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011; 186(10): 5569-5579.10.4049/jimmunol.110028421464089Search in Google Scholar

43. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 2010; 125(5): 1114-1124. 10.1016/j.jaci.2010.01.01820304473Search in Google Scholar

44. Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A. 2007; 104(35): 14080-14085.10.1073/pnas.0700326104195579717715067Search in Google Scholar

45. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001; 167(2): 1081-1089.10.4049/jimmunol.167.2.108111441119Search in Google Scholar

46. Byrne SN, Halliday GM. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. J Invest Dermatol. 2005; 124(3): 570-578.10.1111/j.0022-202X.2005.23615.x15737198Search in Google Scholar

47. Segal BM, Dwyer BK, Shevach EM. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med. 1998; 187(4): 537-546.10.1084/jem.187.4.53722121559463404Search in Google Scholar

48. Peterson LK, Tsunoda I, Fujinami RS. Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity. 2008; 41(5): 353-362.10.1080/08916930801890280439997018568640Search in Google Scholar

49. Hurwitz AA, Sullivan TJ, Sobel RA, Allison JP. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc Natl Acad Sci U S A. 2002; 99(5): 3013-3017.10.1073/pnas.04268469912246411867713Search in Google Scholar

50. Maseda D, Candando KM, Smith SH, et al. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN- γ+CD4+ T cell numbers during colitis development in mice. J Immunol. 2013; 191(5): 2780-2795.10.4049/jimmunol.1300649377031323918988Search in Google Scholar

51. Hurwitz AA, Sullivan TJ, Sobel RA, Allison JP. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc Natl Acad Sci U S A. 2002; 99(5): 3013-3017.10.1073/pnas.042684699Search in Google Scholar

52. Jiang HR, Milovanović M, Allan D, et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur J Immunol. 2012; 42(7): 1804-1814.10.1002/eji.20114194722585447Search in Google Scholar

53. Milovanovic M, Volarevic V, Ljujic B, et al. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype. PLoS One.2012; 7(9): e45225.10.1371/journal.pone.0045225344548323028861Search in Google Scholar

54. Itakura A, Szczepanik M, Campos RA, et al. An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity. J Immunol. 2005; 175(11): 7170-7178.10.4049/jimmunol.175.11.717016301620Search in Google Scholar